On June 12, Keymed Biosciences Inc. (HKEX: 02162) announced that Prof. Jun Shi's research team from the Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences ...

In modern immunotherapy, modified immune cells are introduced into the body to attack tumors and other targets. Researchers ...